Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion
Anuh Pharma Ltd · Financial Result · 30 Oct 2026, 10:30 pm
Anuh Pharma Reports Strong Q2 FY27 Profit Growth Driven by Margin Expansion Anuh Pharma reported Q2 ended 30th Sep'26 revenue from operations of ₹18,524.14 lakhs, marginally lower YoY versus ₹18,588.27 lakhs and down 4.4% QoQ. Despite flat top-line growth, net profit surged 47.3% YoY to ₹1,121.31 lakhs (QoQ: ₹1,142.49 lakhs), driven by operating efficiencies. EBITDA rose 36.5% YoY to ₹1,755.13 lakhs with EBITDA margins expanding 255 bps YoY to 9.47%. Adjusted EBITDA reached ₹1,873.67 lakhs (10.11% margin). EPS stood at ₹1.12. For H1 ended 30th Sep'26, PAT climbed 42.3% YoY to ₹2,263.80 lakhs.
Original exchange filing (PDF)
More announcements from Anuh Pharma Ltd
- Capacity Addition by inauguration of the F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- This is to inform that the Company has inaugurated its new manufacturing facility situated at F-10/1, M.I.D.C., Tarapur, Boisar, District Palghar - 401506, Maharashtra, India. · 16 Nov 2026
- Investor Presentation for Q2 and H1 FY 2026-27 · 06 Nov 2026
- Request received for withdrawal of application for reclassification of shareholding from "Promoter & Promoter Group" to "Public Category". · 30 Oct 2026
- Unaudited Financial Results for the Quarter and half year ended 30th September, 2026. · 30 Oct 2026
- To consider and approve the Unaudited Financial results along with the Limited Review Report for the quarter and half year ended 30th September, 2026 and Request received for withdrawal .... · 30 Oct 2026
- Anuh Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- ANUH PHARMA LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 30 Oct 2026
